Загрузка страницы

Regulating the Regulators: Mechanisms Controlling Function and Metabolism of microRNAs

Regulating the Regulators: Mechanisms Controlling Function and Metabolism of microRNAs

Air date: Wednesday, April 25, 2012, 3:00:00 PM
Time displayed is Eastern Time, Washington DC Local

Category: Wednesday Afternoon Lectures
Description: Micro-Ribonucleic Acids (miRNAs) are a novel class of 20-nucleotide-long regulatory RNAs expressed in eukaryotes. MiRNAs regulate gene expression post-transcriptionally by imperfectly base-pairing to the three prime untranslated region of mRNAs which results in translational repression or mRNA deadenylation and degradation. The number of different miRNAs in human's reaches 1,000, and 50 percent of all human genes are predicted to be subject to miRNA regulation. Although specific functions and target mRNAs have been assigned to only a fraction of identified miRNAs, much evidence exists that miRNAs participate in the regulation of nearly all cellular and developmental processes. Expression of many miRNAs is tissue or development specific and major changes in miRNA expression are observed in human pathologies, including cancer. Clearly, discovery of miRNAs added a new dimension to the complexity and regulation of eukaryotic genomes.

I will discuss current knowledge about the mechanism of miRNA-mediated repression of gene expression, particularly a role of Argonaute and GW182 proteins, and a large multiprotein CCR4-NOT complex which functions downstream and mediates both mRNA deadenylation and translational repression. In addition, biogenesis and turnover of miRNAs, and also the miRNA-mediated repression itself, were recently found to be highly regulated processes involving a plethora of factors with many of them implicated in human pathologies. Finally, I will discuss regulation of miRNA function and turnover in neurons. Our recent work revealed that miRNAs in retinal, hippocampal, and cortical neurons turn over much faster than in non-neuronal cells and that miRNA turnover in neurons may be subject to a complex activity-dependent regulation. Blocking action potentials with tetrodotoxin prevents rapid turnover of miRNAs in neurons. Blocking glutamate receptors likewise prevents decay of many miRNAs in hippocampal and embryonic stem cell derived neurons, while the addition of glutamate accelerates it.

The NIH Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide.

For more information, visit:
The NIH Director's Wednesday Afternoon Lecture Series
Author: Dr. Witold Filipowicz, University of Basel
Runtime: 01:00:41
Permanent link: http://videocast.nih.gov/launch.asp?17234

Видео Regulating the Regulators: Mechanisms Controlling Function and Metabolism of microRNAs канала NIH VideoCast
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
1 мая 2012 г. 0:18:29
01:00:42
Другие видео канала
Gaining New Insights into 'Fundamental Immunology' Using Imaging and ComputationGaining New Insights into 'Fundamental Immunology' Using Imaging and ComputationHeterogeneity of Breast Cancer GenomesHeterogeneity of Breast Cancer GenomesQuality Management in Clinical Research: Preparing for a Successful Quality Visit Part 2Quality Management in Clinical Research: Preparing for a Successful Quality Visit Part 2Data and Safety Monitoring Committees: Trials Needing DSMBs Part 4Data and Safety Monitoring Committees: Trials Needing DSMBs Part 42018 Demystifying Medicine: Compulsive disorders: mechanisms and management2018 Demystifying Medicine: Compulsive disorders: mechanisms and managementAntibodies Against Ebola and Lassa: A Global CollaborationAntibodies Against Ebola and Lassa: A Global CollaborationNeuronal Response to Injury and Stress: Insights from C. elegansNeuronal Response to Injury and Stress: Insights from C. elegansStudy Participant Selection: Example of Participant Selection Part 3Study Participant Selection: Example of Participant Selection Part 3Choosing a Research Question: Developing a Hypothesis and Objectives Part 3Choosing a Research Question: Developing a Hypothesis and Objectives Part 3In Vitro Approaches to Investigate Cell Division and Biological Size ControlIn Vitro Approaches to Investigate Cell Division and Biological Size ControlData Management & Case Report in Clinical Trials: CRF Completion and Query Resolution Part 3Data Management & Case Report in Clinical Trials: CRF Completion and Query Resolution Part 3The Mechanisms of Cytoskeletal Motor ProteinsThe Mechanisms of Cytoskeletal Motor ProteinsQuality of Life: Patient Reported Outcomes: Purpose, Types, Development, and Evaluation Part 1Quality of Life: Patient Reported Outcomes: Purpose, Types, Development, and Evaluation Part 1Medal Winners: How the Vietnam War Launched Nobel CareersMedal Winners: How the Vietnam War Launched Nobel CareersQuality of Life: Interpretation of PRO Scores Part 3Quality of Life: Interpretation of PRO Scores Part 3Developing Protocols & Manuals of Operating Procedures: Informed Consent & Conclusions Part 5Developing Protocols & Manuals of Operating Procedures: Informed Consent & Conclusions Part 5Introduction to Clinical Study Design: Tips for Good Study Design Part 4Introduction to Clinical Study Design: Tips for Good Study Design Part 4Designing Trials Efficiently: Review of Sample Size Considerations Part 2.Designing Trials Efficiently: Review of Sample Size Considerations Part 2.Research With Vulnerable Participants: Vulnerabilities and Safeguards Part 2Research With Vulnerable Participants: Vulnerabilities and Safeguards Part 2Demystifying Medicine 2015 - New Advances in Cancer Diagnosis and Treatment (Immunotoxins)Demystifying Medicine 2015 - New Advances in Cancer Diagnosis and Treatment (Immunotoxins)IPPCR 2019 Overview of Hypothesis Testing Part 4 of 5IPPCR 2019 Overview of Hypothesis Testing Part 4 of 5
Яндекс.Метрика